Molecular Partners AG (XSWX:MOLN)
CHF 3.12 +0.020 (+0.65%) Market Cap: 117.03 Mil Enterprise Value: 41.61 Mil PE Ratio: 0 PB Ratio: 1.71 GF Score: 29/100

Molecular Partners AG conference call and Webcast Transcript

Feb 02, 2026 / 01:00PM GMT
Release Date Price: CHF3.55 (+8.23%)
Operator

Good day and welcome to the Molecular Partners call and webcast. At this time, all participants are in listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question, please press 11. If your question has been answered and you'd like to remove yourself from the queue, please press 11 again. As a reminder, this call may be recorded. I would like to turn the call over to Seth Lewis, head of investor relations and strategy. Please go ahead.

Seth Lewis
Molecular Partners AG - Senior Vice President - Investor Relations and Strategy

Thank you and welcome to today's call. My name is Seth Lewis, head of Investor relations and strategy, and this morning we're following up on the data presented this weekend at the Theranostics World Conference in South Africa for MPO 712, RDLL 3 targeting radiotherapeutic.

This data reflects clinical imaging and dosimetry data that was conducted as part of a named patient access program under the legal framework for compassionate care in South Africa, also referred to as Section

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot